Stay updated with breaking news from Casi long. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com assumed coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Get Rating) in a report issued on Tuesday. The brokerage set a “hold” rating on the biotechnology company’s stock. CASI Pharmaceuticals Price Performance CASI Pharmaceuticals stock opened at $2.77 on Tuesday. The company has a market cap of $36.83 million, a PE ratio of -1.43 […] ....
StockNews.com began coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Get Rating) in a report issued on Monday morning. The firm issued a hold rating on the biotechnology company’s stock. CASI Pharmaceuticals Price Performance Shares of CASI stock opened at $2.64 on Monday. The business has a 50 day simple moving average of $1.92 and […] ....